MSFS
AZN icon

Main Street Financial Solutions’s AstraZeneca AZN Stock Holding History

Main Street Financial Solutions’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$352K Sell
1,917
-246
-11% -$43.1K 0.03% 396
2025
Q3 		$332K Buy
+2,163
New +$327K 0.02% 476
2024
Q4 		– Sell
-1,308
Closed -$204K – 491
2024
Q3 		$204K Sell
1,308
-151
-10% -$24.4K 0.02% 504
2024
Q2 		$227K Buy
+1,459
New +$220K 0.02% 483

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Main Street Financial Solutions's AZN Position: Q4 2025 in Review

Main Street Financial Solutions reduced its AstraZeneca (AZN) stake by 11% in Q4 2025, selling an estimated $43.1K and leaving 1,917 shares worth $352K. The position accounts for 0.03% of the portfolio, ranked #396.

Main Street Financial Solutions first reported a position in AZN in Q2 2024 and has held it in 4 quarters since. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Main Street Financial Solutions held 1,917 shares of AstraZeneca worth $352K as of Q4 2025.
  • Main Street Financial Solutions sold 246 AstraZeneca shares in Q4 2025, an estimated $43.1K.
  • AstraZeneca made up 0.03% of Main Street Financial Solutions's portfolio in Q4 2025, its #396 holding.
  • Main Street Financial Solutions first reported a position in AstraZeneca in Q2 2024 and has held it in 4 quarters since.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Main Street Financial Solutions's 13F filing for Q4 2025, filed 17 Feb 2026.